HC Financial Advisors’s AbbVie ABBV Stock Holding History

HC Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$104K	Buy	678 +100	+17%	+$15.3K	0.07%	96
2022 Q1	$94K	Buy	578 +200	+53%	+$29.1K	0.06%	104
2021 Q4	$51K	Hold	378	–	–	0.03%	137
2021 Q3	$41K	Hold	378	–	–	0.02%	140
2021 Q2	$43K	Hold	378	–	–	0.03%	140
2021 Q1	$41K	Hold	378	–	–	0.03%	141
2020 Q4	$41K	Hold	378	–	–	0.03%	151
2020 Q3	$33K	Sell	378 -307	-45%	-$28.9K	0.02%	143
2020 Q2	$67K	Hold	685	–	–	0.05%	92
2020 Q1	$52K	Buy	+685	New	+$58.3K	0.05%	104

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HC Financial Advisors's ABBV Position: Q2 2022 in Review

HC Financial Advisors increased its AbbVie (ABBV) stake by 17% in Q2 2022, buying an estimated $15.3K and bringing the position to 678 shares worth $104K. The position accounts for 0.07% of the portfolio, ranked #96.

HC Financial Advisors first reported a position in ABBV in Q1 2020 and has held it in 10 quarters since. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

HC Financial Advisors held 678 shares of AbbVie worth $104K as of Q2 2022.
HC Financial Advisors bought 100 AbbVie shares in Q2 2022, an estimated $15.3K.
AbbVie made up 0.07% of HC Financial Advisors's portfolio in Q2 2022, its #96 holding.
HC Financial Advisors first reported a position in AbbVie in Q1 2020 and has held it in 10 quarters since.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on HC Financial Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.